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Serum factors possessing some of the properties of the human rheumatoid 
factor(s) (RF)  1 have been produced in experimental animals. The RF and the 
experimentally  induced  factors  react  with  various  gamma  globulins.  The 
anti-gamma globulin specificities of experimentally induced serum factors can 
be attributed to one or more of the following mechanisms: 
(a) The production of antibodies against heterologous gamma globulin as in 
Adler's  study  (1)  where  sensitized  sheep  cell  agglutinins  developed  in  the 
serum  of  guinea  pigs  immunized  with  heterologous  (rabbit)  immune 
precipitates. 
(b)  The production of iso-antibodies against  rabbit gamma globulin of an 
allotype other than that of the host.  (Studies of rabbit gamma globulin allo- 
types, references (9-12). This was probably operative in the studies of Milgrom 
and Dubiski  (2,  3) who demonstrated sensitized sheep cell agglutinins in rab- 
bits  immunized  with  isologous  antigen-antibody complexes  (Escherickia  coli 
and  Proteus  OX19 agglutinated  by  their  respective  rabbit  antiserum).  The 
hemagglutinating  factor in  each instance  could be absorbed by some  rabbit 
immune complexes but not by all. 
(c)  Immunization  against  gamma  globulin  or  gamma  globulin  products 
which  were  adsorbed  or  assimilated  by bacteria,  utilized for immunization, 
from either culture media or recent passage through animals. This was clearly 
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1 The following  abbreviations, listed in order of appearance, are used throughout the paper. 
RF, rheumatoid factor(s) 
RFLS, rheumatoid factor-like substance 
AHGG, aggregated human gamma globulin 
7S-HGG, non-aggregated human gamma globulin 
7S-RGG, non-aggregated rabbit gamma globulin 
ARGG, aggregated rabbit gamma globulin 
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evident in the study of Lerner et al.  (4) in which a serum factor resulting from 
immunization  of rabbits  with  Streptobacillus  moniliformis  was  dependent  on 
the growth of the microorganisms on media containing human serum protein. 
It may possibly be  operative  in  other  studies  in which rabbits  were  immu- 
nized with  killed  microorganisms  (5,  6). 
(d) The production of anti-antibodies against the host's own gamma  globu- 
lin "denatured"  in the process of combining with  its  respective  antigen.  In a 
study similar  to the present  one, Aho and Wager noted  that 3  of 12  rabbits 
immunized with ovalbumin alone developed a serum factor which agglutinated 
sensitized  sheep cells  (7).  This factor was absorbed  with rabbit  immune pre- 
cipitates  (autologous  and  isologous)  but  not with  horse immune  precipitate. 
Milgrom and Witebsky (8) demonstrated  a  serum factor reactive with human 
gamma  globulin  in  rabbits  immunized  with  their  own  (autologous)  gamma 
globulin prepared by salt fractionation. The authors suggested that denatura- 
tion by physico-chemical means may have occurred during preparation of the 
gamma globulin. They also considered the possibility of immunization against 
contaminating heterologous  (human)  gamma globulin in view of the stronger 
reactivity of the factor with human gamma globulin than with rabbit gamma 
globulin but could not establish  such  a  relationship. 
The present  report concerns the induction of a  rheumatoid factor-like sub- 
stance  (RFLS)  in  2  groups of rabbits  immunized  with  either  formalin-killed 
E. coli or B. subtilis  that were grown in synthetic media free from any source 
of contamination with animal protein. 
Materials and Methods 
1.  Bae2,cria for animal inoculation were cultured  in media containing only inorganic salts 
and glucose.  2 The organisms (E. coli and B. subtilis) had been maintained in this media, with 
frequent transfer, for a period in excess of 2 years. The organisms were killed by the addition 
of formalin (0.4 per cent), and stock suspensions made with normal saline such that a  1:16 
dilution had an optical density of 0.32 at 650 millimicrons in a model 14 Coleman spectro- 
photometer. 
In the studies to be described, 1 unit of bacteria represented 0.5 ml of the stock prepara- 
tion. 
2.  Rabbits injected intravenously with a suspension of killed bacteria. After the first 2 weeks 
of immunization, each animal received 0.6 unit of bacteria  three times weekly. Smaller doses 
were used during the first 2 weeks to minimize endotoxin toxicity. Blood was obtained  at 
approximately  1 month intervals  v/a cardiac or ear artery puncture.  Sera were frozen and 
stored at -20°C. 
3. Serologic methods. All serological procedures utilized  sera  which had  been heated  to 
56°C for 30 minutes. Sera for hemagglutination tests were absorbed with 1 volume of washed, 
packed sheep erythrocytes per 2 volumes of serum. Unless otherwise stated, all dilutions were 
made in phosphate buffered normal saline (pH 8.0). 
2 0.2 per cent ammonium sulfate,  1.4 per cent dibasic potassium phosphate,  0.6 per cent 
monobasic potassium phosphate,  0.1 per cent sodium citrate,  0.02 per cent magnesium sul- 
fate, 0.5 per cent glucose, pH adjusted  to 7.0. J.  L.  ABRUZZ0  AND  C.  L.  CHRISTIAN  793 
The latex fixation tests were performed according to the method of Singer and Plotz (13). 
The sensitized sheep cell agglutination utilized 0.25 per cent cells which had been sensi- 
tized with ~  B.A.T. (basic agglutination titer) of rabbit hemolysin. 
Tanned sheep cell agglutination tests were performed according to the method of Heller 
et  02.  (14).  Materials for adsorption onto  tanned sheep erythrocytes included:  aggregated 
human gamma globulin (AHGG) which represented that part of human Cohn FII  (heated 
60°C for 10 minutes) which was insoluble in 0.62 molar sodium sulfate, non-aggregated human 
gamma globulin (7S-HGG)--the supernatant of heated FII after removal of AHGG,  non- 
aggregated  rabbit gamma  globulin  (7S-RGG),  prepared  by precipitation of  pooled  rabbit 
serum  with  1.35  molar ammonium  sulfate or  ~  saturated  sodium  sulfate and aggregated 
rabbit gamma  globulin  (ARGG)  which was  prepared  by heating  7S-RGG  at  70°C  for  10 
minutes.  All materials were dissolved in buffered saline  (pH  8.0).  Concentrations of these 
materials  used  per 2 ml of 33~  per cent tanned sheep cells were: AHGG  1.7  mg  N,  7S- 
HGG 2.2 mg N,  7S-RGG 3.5 mg N, and ARGG 3.5 mg N. In some experiments the quanti- 
ties of ARGG and AHGG used in "coating cells" were varied as indicated in the text. Saline 
controls and suitable negative and positive serum controls were included in each determina- 
tion. 
Bacterial agglutination tests were performed by adding 1 drop of a  1:2 dilution of stock 
bacteria to  1 drop of a  serially diluted serum on a  Kllne agglutination slide. Macroscopic 
agglutination was recorded as 0 to 4+ after incubation at 37°C for 30 minutes. 
4.  Absorption  experiments  utilized rabbit anti-ovalbumin-ovalbumin immune precipitate, 
human antidextran-dextran immune precipitate,  a E. coli, B. subtilis,  and Salmond~a suspen- 
sions. The quantities of absorbants are indicated in the text. Mter overnight incubation in 
the case of bacterial absorption, or 72 hours incubation at 0 to 4°C for absorptions with immune 
precipitates, the absorbants were removed by centrifugation and serologic studies were con- 
ducted  on the supernatants. 
5.  Inhibition studies. A serum from an E. coil-immunized  rabbit (No. 9) which demonstrated 
RFLS  was used in determining the capacity of AHGG,  7S-HGG,  7S-RGG,  and ARGG to 
inhibit agglutination. 0.25 ml of the test material was serially diluted in 0.25 ml of buffered 
saline and 0.25 ml of diluted No. 9 rabbit serum added to each tube. (Dilution of No. 9 serum 
was ~  of the hemagglutinating titer.) After incubation at room temperature for 30 minutes, 
"coated" erythrocyte reagents were added  to each tube and agglutination tests interpreted 
in the usual manner. 
6.  Precipitation  studies.  Various quantities of ARGG and AHGG were added to aliquots 
of a  normal rabbit serum and a  serum  with RFLS  (No.  9).  (Sera were heated at 56°C for 
30 minutes.) The tubes were incubated 20 hours at 4°C. The N content of the precipitates was 
then determined and tanned cell agglutination tests were performed on the superuatants. 
7.  Density  gradient centrifugation.  A density gradient was prepared, using 10, 20,  30, and 
40 per cent concentrations of sucrose.  1 ml aliquots were carefully layered in a  centrifuge 
tube, with the more dense solutions at the bottom. Mter gentle stirring of the sucrose layers, 
an aliquot serum was carefully layered on top of the sucrose gradient and centrifuged for 16 
hours at  30,000  ae~t  (SW39L  rotor in  Spinco model  L  ultracentrifuge). Top,  middle,  and 
bottom fractions were removed by means of a stabilized needle and syringe and N  contents, 
E. coli agglutinin titers, and FII latex titers  were determined on each fraction. Aliquots of 
each fraction were also absorbed with E. coli, as described previously. 
8.  Mercaptoethanol  treatment.  Mercaptoethanol in  various  concentrations was  added  to 
aliquots of a  serum having known hemagglutinating activity. Mter incubation at 4°C for 24 
hours and dialysis against buffered saline, hemagglutination and E. coli agglutination tests 
were performed. 
3 Serum kindly supplied by Dr.  Elvin A. Kabat. 794  RHEUMATOID  FACTOR-LIKE  SUBSTANCE 
9. Starch block electrophoresis was performed according to  the  method  of Kunkel  (15). 
5 ml of serum were placed on a starch block (pH 8.6) and subjected to 20 ma of current for 
45 hours. The block was cut into 1 cm strips and fractions eluted from each strip with 10 ml 
of normal saline. The N content was determined and tanned cell and E. coli agglutination 
tests were performed on each fraction. 
10.  Nitrogen determined by the  Folin-Ciocalteu method  (16), gamma globulin standards 
(nitrogen determined by Kjeldahl) being included in each series of determinations. 
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FIO. 1.  Development of the rheumatoid factor-like substance (RFLS) ; monthly determina- 
tions of  serum titers  with  aggregated human  gamma globulin (AHGG) "coated"  tanned 
sheep cells. 
RESULTS 
Fig. 1 depicts the development of the RFLS in a group of 5 rabbits immunized 
with E. coll. After 2 months of immunization, the factor could be demonstrated 
in  all  animals. This  contrasts  somewhat  with  a  second  group  of  4  rabbits 
immunized  with B. subtilis (Table I). After 5 months of immunization, only 2 
rabbits had detectable RFLS. In general, the agglutination titers increased as 
immunization progressed. The titers in the various serological systems after 7 
months of immunization with E.  coli  are illustrated in Table II.  Significant 
agglutination titers were observed with tanned sheep cells coated with human 
FIT, AHGG, ARGG,  the  FII latex  fixation  test,  and  with  sensitized  sheep 
E  S 
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cells.  Tanned  cells  coated  with  7S-RGG were not agglutinated  at  the lowest 
dilution  (1:20).  Absorption  studies  are summarized  in Table  III. Absorption 
of  2  sera  (E2  and  No.  9)  with  rabbit  anti-ovalbumin  immune  precipitate 
resulted  in a  marked  reduction of the  tanned  cell agglutination  titers  but no 
change in the E. coli agglutinin titer. The addition of 1 unit of E. coli markedly 
TABLE I 
B. subtilis and rheumatoid  faaor-like substance (RFLS) agglutination titers in rabbits immunized 
with B. subtilis.for 5 months 
Aggregated  rabbit  gamma globulin  (ARGG)-tanned  sheep  cells used  for  "RFLS" ag- 
glutination. 
Rabbit serum 
B1 
Ba 
B, 
B6 
B. sub#ills 
1:10,240 
1:1,280 
1:20,480 
1:1,280 
Agglutination titer 
"RFLS" 
1;320 
<1:10 
1:2,560 
<l:lO 
TABLE II 
Demonstration of RFLS in Serum of Rabbits Immunized with E. coli Using Various 
Agglutination Tests 
Tanned cell agglutinations 
gabbit serum  "Coating materials" 
7 mos. 
mmunization 
E2 
F~ 
No. 2 
No. 9 
Hunlan 
Cohn FII 
1:80 
1:20 
1:20 
1:320 
Non-aggre- 
gated human 
GG 
1:20 
<1:20 
<1:20 
1:20 
Aggregated 
human GG 
1:160 
1:40 
1:80 
1:640 
Non-aggre- 
rabbit GG  gat%~bbit  Aggregated 
<1:20  1:1280 
<1:20  1:40 
<1:20  1:160 
<1:20  1:1280 
Sensitized 
FII l~tex  sheep  cell 
fixation  agglutina- 
tions 
1:256  1:256 
1:8  1:32 
1:2048  1:128 
1:2048  1:512 
reduced  the  titer  of  RFLS  but  an  insignificant  reduction  (1  tube  dilution) 
occurred after absorption with a  comparable quantity  (1 unit)  of Salmonella. 
12 units of E. coli lowered the E. coli agglutinin titer as well as the tanned cell 
titers.  Twelve units of Salmonella still produced only a  slight reduction in the 
tanned  cell  titers  and  did  not affect R.  coli  agglutinin  titers.  Additional  ab- 
sorption data is presented in Table IV. 1 unit of E. coli again effectively removed 
the RFLS from an E. coil-immunized rabbit  (E14) but not from a B. subtilis-- 
immunized  rabbit  (B,)  whereas  the opposite occurred with B. subtilis absorp- 
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Absorption  by  a  rabbit  immune  precipitate  (ovalbumin,  anti-ovalbumin) 
resulted  in a  marked reduction  of both  the AHGG tanned  cell titer and  the 
ARGG  tanned  cell  titer  (see  Tables  III and  V).  The  addition  of  a  human 
TABLE  III 
Absorption  Study,  Demonstrating  Removal  of  "RFLS"  from  0.3  Ml  Serum  by  an  Immune 
Complex  and E. coli 
Rabbits were immunized with E. coli. 
Rabbit 
serum 
E2 
No. 9 
E2 
No. 9 
E2 
No. 9 
E2 
No. 9 
Agglutination system 
E. coli-anti-E,  coil 
Cohn FII-tanned sheep cells 
Aggregated human GG- 
tanned sheep cells 
Aggregated rabbit GG- 
tanned sheep cells 
Absorbed  [ 
Unab-  [  with  ] 
sorbed  immune  [ 
preclpitate* I 
1:10,000  I  1:10,000 
1:20,000  /  1:20,000 
Agglutination titers 
1:80 
1:320 
1:320 
1:1280 
1:1280 
1:1280 
Absorbed with  ]  Absorbed with 
_  E. coli  Salmonella 
1 unit  12 units  1 unit  12 units 
1:10,000  1:160  ]  1:10,000  I  1:10,000 
1:20,000  1:320  I  l:20,000  ]  1:20,000 
1:20  <1:20  <1:20 
<1:20  <1:20  1:20 
1:20  1:20  1:20 
1:20  <1:20  1:40 
<1:20  1:20  <1:20 
1:20  1:20  <i:20 
* Immune precipitate  =  ovalhumin-anti-ovalbumin  (0.4 mg nitrogen). 
1:40  1:40 
1:320  1:80 
1:160  1:160 
1:640  1:320 
1:640  I:16t) 
1:1280  1:640 
TABLE  IV 
Absorption Study 
Effect of absorption of sera of E. coli and B. subtills immunized animals with respective 
bacteria. 
Serum" 
E, (E. coli-immunized) ................. 
B,  (  B. subtilis-immunized) ............. 
ARGG-tanned sheep cell agglutination 
Unabsorbed  Absorbed with  Absorbed with 
E. coil,  1 unit  B. subtilis 1 unit 
1:1280  1:80  1:1280 
1:2560  1:2560  1:40 
* 3  ml of 1 : 10 dilution of sera. 
immune precipitate (dextran--anti-dextran)  resulted in a marked reduction of 
the AHGG tanned cell titer but only a twofold reduction of the ARGG tanned 
cell titer  (Table V). 
Inhibition Studies.--Table VI indicates the relative capacities of rabbit and 
human gamma globulin  reactants  to  inhibit  the  agglutinating  property of a 
serum with RFLS (No. 9). Although minimal amounts of AHGG (0.1)3 micro- j.  L.  ABRUZZO  AND  C.  L.  CHRISTIAN  797 
grams N) inhibited agglutination of AHGG tanned cells, 64,000 times as much 
AHGG (1.922 rag) did not inhibit agglutination of ARGG tanned cells. 
ARGG  inhibited  hemagglutinating  activity  in  both  test  systems.  ARGG 
containing  0.88  micrograms N  inhibited  the  ARGG tanned cell reaction and 
TABLE  V 
Absorption Study  Showing  "Species"  Effect on  Removal of RFLS with  Immune Complexes 
Tanned sheep  cell agglutination  system 
Aggregated rabbit gamma globulin- 
"coated" 
Aggregated human gamma 
globulln-"coated" 
Es unabsorbed 
1:1280 
1:640 
Agglutination titers 
E* absorbed with 
human immune 
precipitate* 
1:640 
1:20 
Es absorbed with 
rabbit immune 
precipitate~ 
1:20 
1:10 
* Dextran-antidextran precipitate  (0.36 mg nitrogen). 
Ovalbumin-anti-ovalbumin precipitate (0.36 mg nitrogen). 
TABLE  VI 
Inhibition of RFLS with Human and Rabbit GG, Demonstrating the Effect of Aggregation and 
Species Differences 
Agglutination system 
Aggregated human GG- 
"coated" tanned ceils 
Aggregated rabbit GG- 
"coated" tanned cells 
Minimum quantity (micrograms Nt) required to inhibit 
4 units of rabbit hemagglutinating  factor (No. 9) 
Human gamma globulin  Rabbit gamma globulin 
Aggregated 
0.03 
No inhibition at 
1,922.0 
Nonaggregated 
No inhibition at 
1,800.0 
No inhibition at 
1,800.0 
Nonaggregat  ed 
17.5 
No inhibition at 
1,115.0 
Aggre- 
gated 
14.1 
0.88 
ARGG containing  14.1  micrograms N  blocked AHGG tanned  cell agglutina- 
tion. 
Inhibition  of  agglutination  of  tanned  cells  coated  with  either  AHGG  or 
ARGG was  not  observed  with  7S-RGG.  7S-HGG failed  to  inhibit  ARGG- 
coated tanned cells, but in relatively high concentration inhibited agglutination 
of AHGG-coated cells. 
Precipitation  Studies.--Fig.  2  illustrates precipitin  studies in which AHGG 
and ARGG were added to No. 9 rabbit serum with RFLS and a  serum from a 
non-immunized rabbit.  The quantity  of precipitate formed in  the immunized 798  RHEUMATOID  FACTOR-LIKE  SUBSTANCE 
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Fie.  2.  Precipitin studies.  Effect  of aggregated  gamma  globulins  (human  and  rabbit) 
added to normal rabbit serum and a serum with RFLS (No.  9).  Figures at the top of each 
graph represent supernatant titer. 
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rabbit was  greater  than  that  formed in  the  non-immunized  (control)  rabbits 
at  every  concentration  of  added  aggregated  gamma  globulin.  Serological 
studies of the supernatants resulting from the addition of ARGG demonstrated 
a  substantial reduction of titers in both systems  (ARGG- and  AHGG-coated j.  L.  ABRUZZO AND  C.  L.  CHRISTIAN  799 
tanned cells). In contrast, supernatants  of the serum after precipitation with 
AHGG retained agglutinating activity with ARGG-coated cells (1  tube drop 
in titer--l:640 to 1:320) but failed to agglutinate AHGG-coated cells. 
Density Gradient Centrifugation  Studies.--Table  VII summarizes an experi- 
ment in which rabbit serum 9 was subjected to density gradient centrifugation 
and separated into 3 fractions (top, middle, and bottom). The E. coli agglutinins 
were concentrated in the top and middle fractions while the RFLS (FII latex 
agglutination) was contained in the bottom fraction. When agglutination tests 
were repeated after absorption with 1 unit of E. coli, the bottom fraction, which 
contained  minimal  coli  agglutinins,  demonstrated  a  reduction  of  FII  latex 
titer from 1:640 to 1:320. Comparable absorption of whole serum resulted in 
removal of the FII latex agglutinating property. 
TABLE  VII 
Separation  of  RFLS  from  E.  coli  Agglutinins  by  Preparative  Centrifugation 
Density gradient  fraction 
Top 
Middle 
Bottom 
Whole serum (Rabbit 9) 
1.79 
1.76 
0.48 
Unabsorbed 
E. ~li tier  FII latex titer 
1:2560  <1:20 
1:5120  <1:20 
1:320  1:540 
1:20,480  1:160 
Absorbed with E. coli 
E. coli titer  FII ~tex titer 
1:80  <1:20 
<1:20  1:320 
1:5120  <1:20 
Mercaptoethanol  Studies.--Table  VIII illustrates the results obtained when 
various  concentrations of mercaptoethanol were added  to  aliquots  of serum 
(E2) containing the RFLS. The ARGG and the AHGG tanned cell titers both 
decreased after the addition  of 0.01  M mercaptoethanol  (the lowest concen- 
tration used). The E.  coli  agglufinin fiter remained unchanged. 
When the concentration of mercaptoethanol in the serum was increased to 
0.2 M, the ARGG and AHGG titers were both  <  1:20, while the E. coli titer 
decreased from 1:10,240  to  1:5,120. 
Starch  Block  Electrophoresis.--Analysis  of  the  eluted  fractions  of  No.  9 
serum provided the data shown in Fig. 3. The peak titers of E. coli agglutinins 
were present in fractions -- 1 to -- 7 (cathodal migration). The highest titers of 
ARGG tanned cells and AHGG tanned cells were both contained in fraction 
-- 1 to -}-4, corresponding to the more rapidly anodal migrating gamma globulin 
and beta globulin range. Nitrogen concentrations of the eluants are plotted in 
the top graph of the figure. 
DISCUSSION 
Rabbits immunized for several weeks with formalin-killed bacteria developed 
a serum factor which, in properties so far studied, resembled the human rheu- 800  RHEUMATOID FACTOR-LIKE SUBSTANCE 
matoid factor (RF). The rabbit rheumatoid factor-like substance (RFLS) was 
a heat-stable  (560C) 4 protein which migrated electrophoretically in the gamma 
globulin  to beta  globulin  range  (Fig.  3).  In  density gradient  centrifugation 
studies,  the  RFLS  sedimented  more  rapidly  than  antibacterial  antibodies 
(Table VII). Other indirect evidence for the macroglobulin nature of the RFLS 
derived from observations that mercaptoethanol, in  concentrations  that  did 
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FIG. 3.  Starch block electrophoresis  showing migration of the RFLS (center illustration) 
as a beta or gamma globulin. Migrations of the E. coli antibodies are shown in the bottom 
illustration. (Anode  to the right). 
not affect agglutination of bacteria by antibacterial antibodies, destroyed the 
RFLS  (Table VIII).  The RF,  like  other human  macroglobulins  of  the  19S 
class of globulins, is reduced to smaller fragments, with resultant loss of sero- 
logical activity, by a  variety of sulfhydryl reagents  (17,  18). The RFLS ag- 
glutinated FII-"coated"  latex, FII-"coated"  tanned sheep cells, and sensitized 
sheep cells; and, like the human RF, precipitated with aggregates of human or 
rabbit gamma globulin. 
4 A  heat-labile factor in normal sera, probably related to the complement system, shares 
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The RFLS was removed by absorption with immune complexes formed from 
human  and  rabbit  antiserum  (immune  complexes included:  dextran-human 
antidextran,  bovine  serum  albumin-rabbit  anti-BSA,  ovalbumin-rabbit 
antiovalbumin).  Immune  complex  formation  between  bacterial  and  anti- 
bacterial  antibodies appeared  to mediate  the removal  of RFLS in bacterial 
absorption studies. E. coli removed the RFLS from the serum of an E.  coli- 
immunized  rabbit  but did not affect the  titer  of serum  from  a  B.  subtilis- 
immunized animal, and the reverse was noted with absorption of the sera with 
B. subtilis (Table IV). The RFLS in a preparation with a low titer of E. coli 
agglutinins was incompletely removed by the addition of a quantity of E. coli 
which effectively absorbed the RFLS from whole serum (Table VII). 
TABLE VIII 
Effect  of  Various  Concentrations of Mercaptoethanol on  the  RFLS  and  E.  coli Agglutinins 
Concentration of mercaptoethanol 
in treated serum (E2) 
None 
0.01 Mo]ar 
0. 025 Molar 
0.05 Molar 
0.2 Molar 
Hemagglutination tlter "tanned eel] system" 
Aggregated human 
GC~"Coated" 
1:320 
1:80 
1:40 
< 1:20 
<1:20 
Aggregated rabbit 
GG-"Coated" 
1:1,280 
1:640 
1:160 
1:40 
<1:20 
E. coU 
agglutination titer 
1:10,240 
1:10,240 
1:10,240 
1:10,240 
1:5,120 
Studies of (a) hemagglutination inhibition by ARGG and AHGG (Table VI), 
(b)  precipitation  induced  by ARGG and  AHGG and  serological  analysis of 
supernatants  (Fig.  3), and  (c) differential absorption with rabbit and human 
immune  precipitates  (Table  V)  all  demonstrate  a  consistent  pattern  with 
reference to species specificity of the RFLS. Aggregates of rabbit GG (either 
ARGG or rabbit immune  complexes)  absorbed completely the agglutinating 
activity for cells  "coated" with ARGG or AHGG.  Absorption with human 
gamma globulin aggregates,  however, removed only agglutinating  activity for 
AHGG-"coated"  cells,  leaving  in  the  supernatant  agglutinins  for  ARGG- 
coated cells. These data suggest that the RFLS has specificity directed primarily 
against rabbit gamma globulin with cross-reactivity for human gamma globulin. 
The reverse relationship applies to the human RF and its reactions with human 
and  rabbit  gamma  globulins.  Absorption  of  rheumatoid  sera  with  rabbit 
immune  complexes  (immune  precipitates  or  sensitized  sheep  cells)  removes 
sensitized  sheep  cell  agglutlnlns  but  leaves  activity  for  serological  systems 
utilizing  human reactant gamma globulin (22-24). 
The development of the RFLS in the present study is clearly not a  conse- 
quence of immunization against gamma globulin of hetero]ogous or homologous 802  RHEUMATOID  FACTOR-LIKE  SUBSTANCE 
origin, nor could it be attributed to antibody production specifically against 
intrinsic antigens of the bacteria utilized for immunization. Rather, it is sug- 
gested  that,  during  the  course  of  prolonged  immunization  the  continued 
formation and elimination of immune complexes stimulates the production of a 
factor  (RFLS)  whose  specificity is  directed  against  the  host's  own  gamma 
globulin  in  the  aggregated  state  (either induced  by immune reaction or  by 
physical  treatment).  The  concept  of  specificity  against  "immunologically 
denatured" gamma globulin was suggested by Milgrom (25) for certain human 
and rabbit sere that react with sensitized cells and by Coombs (26) for com- 
plement reactants in the immunoconglutinin system. It is possible that immune 
aggregation  exposes  "new"  antigenic  determinants  on  the  gamma  globulin 
molecule. In the present studies, the development of the RFLS paralleled the 
duration of immunization and the intensity of the immune response to bacterial 
antigens. All animals that received E. coli injections for 8 weeks or more de- 
veloped the factor. B.  subtilis,  a  poor antigen in contrast to E.  coli, induced 
detectable RFLS  only in  animals  that  demonstrated bacterial agglutinins  in 
high titer (Table I). 
The RFLS in the present study closely resembles that studied by Aho  5 and 
possibly by Eyquem but its properties differ uniquely from other experiment- 
ally induced serum factors. Rabbits immunized with streptococci or the host's 
own gamma globulin in Milgrom and Witebsky's studies, developed a  serum 
factor with primary specificity for human gamma globulin which reacted poorly 
with rabbit gamma globulin (5). Furthermore, the requirement for aggregation 
of  reactant  gamma  globulin  was  not  apparent  in  their  studies.  Precipitin 
bands, with gel diffusion techniques, were obtained with native human gamma 
globulin.  6 When rabbits were immunized with bacteria agglutinated by homol- 
ogous antisera,  the induced serum factor, which agglutinated sensitized sheep 
cells could be absorbed by the sensitized bacteria utilized for immunization but 
not by a different immune complex (2). The possibility that these observations 
related to homologous immunization with different allotypic gamma globulins 
was subsequently suggested by one of the authors (27). In the present studies, 
the  RFLS  was  absorbed  by  any  rabbit  immune  complex,  regardless  of  the 
antigen or the source of rabbit antibody. 
The presence of the RFLS in hyperimmune sera of any type would be ex- 
pected to participate in  quantitative precipitin analyses,  unless  the  antisera 
were first absorbed with immune precipitate from an unrelated immune system. 
5 A  possible difference concerns reactivity of the RFLS in  the sensitized Rh cell system. 
We were unable to evaluate this in our study because the sere containing RFLS agglutinated 
unsensitized as well as sensitized Rh"+"  cells. After absorption of the sera with Rh"+" 
cells, there was no agglutination of either sensitized or unsensitized cells. 
6 In our studies, rabbit sere with the RFLS sometimes formed hazy diffuse zones of pre- 
cipitate with aggregated gamma globulin reactants but did not  visibly react with native 
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Thus, the RFLS may  represent  in  part  the  co-precipitating  factors  in  im- 
mune sara. 
The similarity of the RFLS to RF is apparent. Both factors are heat-stable 
macroglobulins  whose  serological  specificities  are  directed  against  gamma 
globulin in an aggregated state. Studies of species specificity are consistent: 
the rabbit RFLS is incompletely absorbed by human immune aggregates, and 
the human RF is incompletely absorbed by rabbit immune aggregates.  The 
rabbit  RFLS appears  to result from prolonged immunization; the genesis of 
the human RF is not known. In this respect, however, it is interesting that 
the human RF has been associated with a  variety of non-rheumatoid states 
such  as  leprosy  (28),  kala  azar  (29),  syphilis  (30),  pulmonary tuberculosis 
(31),  chronic liver disease (32),  and sarcoidosis (29).  In at least some of these 
states, a  sustained immunologic response to the antigens of micro-organisms 
is  likely.  7 Thus,  the  old  question  of  an  infectious etiology for  rheumatoid 
arthritis, though lacking support from microbiological studies, might gain some 
emphasis from a clearer understanding of the RF. The possibility that the RF 
is a host response to sustained contact with an environmental antigen, living 
agent or otherwise, deserves consideration. 
Consideration  should  be  given  to  possible  genetic  factors  which  might 
operate  in  the  development of the  RF.  Two studies have  indicated  that a 
higher  than  normal  incidence of  the  RF  occurs  in  relatives  of rheumatoid 
subjects (33, 34).  Patients with rheumatoid arthritis might possess a defect in 
some, as yet uncharacterized facet of host resistance which impedes elimination 
of antigenic substances,  favoring a  sustained antigenic stimulus.  (In  agam- 
maglobulinemia a  diminished or  absent  capacity  to  form  serum  antibodies 
exists, in the face of seemingly normal mechanisms for the cellular immune 
response; i.e.,  delayed hypersensitivity (35).)  In this respect, it is of interest 
that  some  interrelationship  may exist  between  agammaglobulinemia, rheu- 
matoid arthritis, and th,e RF. Fudenberg and German (36)  and Rodnan (37) 
have noted a  higher than expected incidence of rheumatoid arthritis and the 
RF  in  relatives  of patients  with  agammaglobulinemia, and  a  chronic sero- 
negative arthritis has been observed in as many as one-third of subjects with 
agammaglobulinemia (38-40). 
There  has been  no discussion of the  questions:  (a)  is  the  induced RFLS 
antibody in the classical sense, and (b) if it is auto-antibody against the host's 
own gamma globulin, does it (or its human counterpart, the RF) in any way 
mediate  disease  processes.  Answers  to  these  questions  are  equivocal.  One 
could  consider  the  RFLS  as  complement-like  rather  than  antibody-like. 
Rabbits with high titers of RFLS have not demonstrated gross or pathologic 
7 One patient has been encountered by the authors with subacute bacterial endocarditis 
(Streptococcus viridans)  who demonstrated  positive rheumatoid  serological  reactions. 804  RHEUMATOID  FACTOR*LIKE  SUBSTANCE 
features  of  arthritis.  (Lesions  so  far  identified  are  compatible  with  chronic 
serum sickness.) 
SUMMARY 
Hyperimmunization  of  two  groups  of  rabbits  with  killed  Escherichia  coli 
and Bacillus subtilis has resulted in the formation of a  serum factor (RFLS) 
which resembled the human rheumatoid factor. It was a  heat-stable protein 
that  migrated  electrophoretically  in  the  gamma-beta  globulin  range  and 
sedimented  rapidly with ultracentrifugation.  The serologic properties of the 
RFLS  were destroyed by mercaptoethanol. It  reacted primarily with  rabbit 
gamma  globulin  in  an  aggregated  state  (immune  complexes  or  physically 
aggregated  gamma  globulin)  and  demonstrated  cross-reactivity with  human 
gamma globulin. 
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